Skip to main content

Sarah Williams

Chief Accounting Officer

AN2 Therapeutics, Inc. (ANTX)

Equibles does not estimate personal net worth.

Get an email with a short summary when AN2 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ANTX alerts

About Sarah Williams

Sarah Williams is recorded as Chief Accounting Officer at AN2 Therapeutics, Inc. (ANTX) since February 1, 2026. AN2 Therapeutics, Inc. reported in an 8-K filed January 29, 2026 that Sarah Williams was appointed Vice President, Controller and Principal Accounting Officer, effective February 1, 2026. AN2 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at AN2 Therapeutics, Inc. includes Eric Easom (CEO and Board Member), Lucy Day (CFO and Chief Accounting Officer), Josh Eizen (COO) and 7 others.

“On January 26, 2026, the Board of Directors (the “Board”) of AN2 Therapeutics, Inc. (the “Company”) appointed Sarah Williams as Vice President, Controller and Principal Accounting Officer of the Company.”
AN2 Therapeutics, Inc. Form 8-K, filed January 29, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at AN2 Therapeutics, Inc.

Recent activity